| (3/8/2001) |
Medical Devices; Final Guidance for Staff, Industry, and Third Parties Implementation of Third Party Programs Under the FDA Modernization Act of 1997; Availability |
| |
Related Document: Implementation of Third Party Programs Under the FDA Modernization Act of 1997 - February 2001. |
| (8/9/2000) |
Guidance for Industry and for FDA Reviewers; Guidance on Section 216 of the Food and Drug Administration Modernization Act of 1997; Availability |
| (9/1/99) |
Medical Devices; Draft Guidance on Evidence Models for the Least Burdensome Means to Market; Availability. |
| |
Related Document: Evidence Models for the Least Burdensome Means to Market. |
| (4/27/99) |
Draft Guidance on Resolving Scientific Disputes Concerning the Regulation of Medical Devices; Administrative Procedures on Use of the Medical Devices Dispute Resolution Panel ; Availability |
| |
Related Document: Draft Guidance on Resolving Scientific Disputes Concerning the Regulation of Medical Devices; Administrative Procedures on Use of the Medical Devices Dispute Resolution Panel |
| (2/12/99) |
Modernization Act of 1997: Guidance on Medical Device Tracking; Availability |
| |
Related Document: Guidance on Medical Device Tracking (Issued 2/99) |
| (1/26/99) |
Guidance on Amended Procedures for Advisory Panel Meetings; Availability |
| (11/5/98) |
Guidance for Industry on General/Specific Intended Use; Availability |
| |
Related Document: Guidance for Industry on General/Specific Intended Use |
| (11/3/98) |
Guidance on Criteria and Approaches for Postmarket Surveillance; Availability |
| |
Related Document: Guidance on Criteria and Approaches for Postmarket Surveillance |
| (11/3/98) |
SMDA to FDAMA: Guidance on FDA's Transition Plan for Existing Postmarket Surveillance Protocols; Availability |
| |
Related Document: SMDA to FDAMA: Guidance on FDA's Transition Plan for Existing Postmarket Surveillance Protocols |
| (11/2/98) |
Guidance for Staff, Industry, and Third Parties: Implementation of Third Party Programs Under the FDA Modernization Act of 1997; Availability |
| |
Related Document: Implementation of Third Party Programs Under the FDA Modernization Act of 1997 |
| (7/02/98) |
Draft Guidance for Staff, Industry and Third Parties: Third Party Programs Under the Sectoral Annex on Medical Devices to the Agreement on Mutual Recognition Between the United States of America and the European Community; Availability |
| (5/22/98) |
Draft Guidance for Staff, Industry, and Third Parties: Implementation of Third Party Programs Under the FDA Modernization Act of 1997; Availability |
| (5/22/98) |
Guidance for Industry on General/Specific Intended Use; Draft; Availability |
| (5/21/98) |
Guidance for Industry, Supplements to Approved Applications for Class III Medical Devices: Use of Published Literature, Use of Previously Submitted Materials, and Priority Review; Availability |
| (4/01/98) |
Guidance to Industry and CDRH for PMAs and PMA Supplements: Use of Published Literature, Use of Previously Submitted Materials, and Priority Review; Draft; Availability |
| (3/31/98) |
PMA/510(k) Expedited Review Guidance for Industry and Center for Devices and Radiological Health Staff; Availability |
| (3/4/98) |
Medical Devices; Device Tracking; New Orders to Manufacturers |
| (3/4/98) |
FDA Modernization Act of 1997: Guidance on Medical Device Tracking; Availability |
| (2/25/98) |
FDA Modernization Act of 1997: Guidance for the Recognition and Use of Consensus Standards; Availability |
| (2/25/98) |
FDA Modernization Act of 1997; Guidance Documents for the Medical Device Industry; Availability |
| (2/25/98) |
Medical Devices; Postmarket Surveillance; Guidance Documents; Availability |
| (2/25/98) |
Guidance for Industry on Medical Device Appeals and Complaints: A Guidance on Dispute Resolution; Availability |
| (2/6/98) |
FDA Modernization Act of 1997: Guidance for the Device Industry on Implementation of Highest Priority Provisions; Availability |